ESR1 and breast cancer: Triple-negative breast cancer (TNBC), characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu), is an aggressive subtype of breast cancer with limited treatment options1.